- Category
- Micro (2021-22)
- Udyam number
- UDYAM-OD-19-0022852

DRS RX Pharma Private Limited
About DRS RX Pharma Private Limited
Data last updated:
DRS RX Pharma Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U51909OR2021PTC038470. Its GSTIN is 21AAICD9705A1Z5 (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Susanta Kumar Chhotaray (Managing Director) and Rakesh Kumar Pradhan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 295/406 Bijipur Tamando P.S – Khurda, Bhubaneswar, Odisha, India – 752054.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.02 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net loss of ₹15.95 Lakh (net margin -15.6%) and EBITDA of -₹4.19 Lakh (EBITDA margin -4.1%).
DRS RX Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-19-0022852).
Company details
Recognitions & Rankings of DRS RX Pharma
Contact details
DRS RX Pharma Private Limited's registered office is in Bhubaneswar, Odisha. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No – 295/406 Bijipur Tamando P.S – Khurda, Bhubaneswar, Odisha, India – 752054
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of DRS RX Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of DRS RX Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of DRS RX Pharma Private Limited, buy the company report.
Financials of DRS RX Pharma Private Limited
FY 2025 filings availableDRS RX Pharma Private Limited reported revenue of ₹1.02 Cr (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year. EBITDA rose 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹4.19 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹15.95 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -4.1% | |||
| Net Profit Margin | -15.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of DRS RX Pharma Private Limited, buy the company report.
Board of directors of DRS RX Pharma Private Limited
DRS RX Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Susanta Kumar Chhotaray | Managing Director | 20 Dec 2021 | 4 Years 10 Months | Current |
| Rakesh Kumar Pradhan | Director | 20 Dec 2021 | 4 Years 10 Months | Current |
Peer comparison
DRS RX Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Janus Life Sciences Private Limited | ₹1.02 Cr (FY 2025) | -7.0% | Delhi, India | |||
| Yrc Pharmaa Merchant Private Limited | ₹1.02 Cr (FY 2024) | Lucknow, Uttar Pradesh, India | ||||
| DRS RX Pharma Private Limitedthis company | ₹1.02 Cr (FY 2025) | -₹15.95 Lakh | -15.6% | -12.0% | Bhubaneswar, Odisha, India | |
| Bravion Bioscience Private Limited | ₹1.02 Cr (FY 2024) | -24.0% | Sitamarhi, Bihar, India |
To see the full peer comparison of DRS RX Pharma Private Limited, buy the company report.
Auditor
DRS RX Pharma Private Limited is audited by A.C BEHERA & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.C BEHERA & CO | FY 2022 | 327945E |
Shareholding
The shareholding of DRS RX Pharma Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of DRS RX Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving DRS RX Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for DRS RX Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
DRS RX Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAICD9705A1Z5 | Odisha | Active | 16 Feb 2022 |
To see the full GST registrations and return filing status of DRS RX Pharma Private Limited, buy the company report.
Recent activity
DRS RX Pharma Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Deepak Kumar Jena ceased to be Director on 01 May 2024.
Frequently asked questions
DRS RX Pharma is an active private limited company based in Bhubaneswar, Odisha, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 December 2021 (5+ years old) and is registered under CIN U51909OR2021PTC038470.
DRS RX Pharma has 2 current directors:
- Susanta Kumar Chhotaray - Managing Director
- Rakesh Kumar Pradhan - Director
The latest financial statements of DRS RX Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of DRS RX Pharma is 21AAICD9705A1Z5, registered in Odisha.
The CIN (Corporate Identification Number) of DRS RX Pharma is U51909OR2021PTC038470. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DRS RX Pharma was incorporated on 20 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of DRS RX Pharma by revenue are Janus Life Sciences Private Limited, Yrc Pharmaa Merchant Private Limited, Bravion Bioscience Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Deepak Kumar Jena ceased to be Director on 01 May 2024. Rakesh Kumar Pradhan was appointed as Director on 20 Dec 2021. Susanta Kumar Chhotaray was appointed as Managing Director on 20 Dec 2021.
Yes, DRS RX Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-19-0022852).
The registered office of DRS RX Pharma is at Plot No – 295406 Bijipur Tamando P.S – Khurda, Bhubaneswar, Odisha, India – 752054.
DRS RX Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

